Diagnosed with advanced prostate cancer in 2018, the journey was filled with challenges. Through innovative treatments, clinical trials, and unwavering support from family and MD Anderson, hope emerged. Today, the mission is to raise awareness and funds, ensuring others have the tools to fight their own battles
Inspiring Prostate Cancer Journey and the Power of Support Read More »
Discover how a 75-year-old patient with advanced small cell lung cancer overcame initial adversity through combination immunochemotherapy, achieving complete regression before ultimately transitioning to palliative care due to disease progression. This journey highlights the power of timely interventions and personalized treatment plans.
A Triumphant Fight Against Small Cell Lung Cancer Read More »
David, now 76, recalls childhood road trips with his father’s fascination for cemeteries. Four years ago, when confronted with stage 4 liver cancer that had spread to his lung, he ordered a tombstone—only to discover that his life’s achievements were too numerous for a simple marker.
From Selma to Survival: An Ongoing Triumph Over Stage IV Liver Cancer Read More »
Discover how cutting-edge immunotherapy allowed Dave M. to defy a terminal bladder cancer prognosis, regain his health, and share priceless moments with his family once again
Journey from Terminal Bladder Cancer to Renewed Hope Read More »
Discover a remarkable metastatic bladder cancer journey marked by radical surgery, cutting-edge immunotherapy, and dragon boat racing, culminating in a complete response thanks to an innovative clinical trial featuring atezolizumab.
Finding Hope with Advanced Therapies and Remarkable Support System Read More »
Experience a powerful stage IV urothelial cancer journey, featuring groundbreaking clinical trials at Memorial Sloan-Kettering, expert oncology care, and an inspiring story of faith and family support
Miraculous Stage IV Urothelial Cancer Journey: A Triumph of Innovation Read More »
After discovering a lump at 48, Cindy was diagnosed with BRCA1-positive triple-negative breast cancer. Through aggressive chemotherapy, a double mastectomy, and enrolling in a clinical trial, she remains in remission—crediting her recovery to genetic insights, advanced treatments, and an unwavering support system.
Confronting Triple-Negative Breast Cancer: A Story of Hope and Resilience Read More »
Stage IV NSCLC survivor Melissa C. has outlasted dire predictions through genetic testing, clinical trials, and a steadfast commitment to advocacy. Her journey proves that targeted therapies and a positive mindset can transform the fight against advanced lung cancer.
An Ongoing Triumph Over Stage IV Lung Cancer Read More »
Stage 4 lung cancer patient Sara Whitlock was given just a 3% chance of surviving five years. Thanks to targeted therapy through a clinical trial, she has no signs of disease nearly a decade later, illustrating the power of personalized treatments in extending both life and hope.
Nine Years Beyond a 3% Survival Chance of Stage IV NSCLC Read More »
After her breast cancer recurred and metastasized, Janet K. participated in a clinical trial for palbociclib, which has kept her disease in check for more than five years.
Hope in Innovation: Story of Clinical Trial Success Read More »
